癌症相关性贫血的治疗进展

Q4 Medicine

肿瘤研究与临床 Pub Date : 2019-10-28 DOI:10.3760/CMA.J.ISSN.1006-9801.2019.10.015

F. Ye

{"title":"癌症相关性贫血的治疗进展","authors":"F. Ye","doi":"10.3760/CMA.J.ISSN.1006-9801.2019.10.015","DOIUrl":null,"url":null,"abstract":"Cancer-related anemia (CRA) is a complication of tumor patients in the development and treatment of diseases. Studies have shown that the incidence of anemia in non-hematologic malignancies is about 40%, and the incidence can reach 54% during tumor radiotherapy and chemotherapy. The pathogenesis of CRA has not been fully clarified, and studies at home and abroad are also very limited. The quality of life and prognosis of CRA patients are poor. In China, due to the imbalance of economic level and the development of medical conditions, doctors in different levels of medical units have different levels of understanding and attention to CRA. Therefore, it is particularly important to strengthen the standardized diagnosis and treatment of CRA. The effectiveness and safety of the presently accepted therapeutic approaches are defined. The new treatment methods are still in the research stage. The article reviews the status of diagnosis and treatment of CRA. \n \n \nKey words: \nNeoplasms; Anemia; Pathogenesis; Treatment","PeriodicalId":9505,"journal":{"name":"肿瘤研究与临床","volume":"31 1","pages":"707-711"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Treatment progress of cancer-related anemia\",\"authors\":\"F. Ye\",\"doi\":\"10.3760/CMA.J.ISSN.1006-9801.2019.10.015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cancer-related anemia (CRA) is a complication of tumor patients in the development and treatment of diseases. Studies have shown that the incidence of anemia in non-hematologic malignancies is about 40%, and the incidence can reach 54% during tumor radiotherapy and chemotherapy. The pathogenesis of CRA has not been fully clarified, and studies at home and abroad are also very limited. The quality of life and prognosis of CRA patients are poor. In China, due to the imbalance of economic level and the development of medical conditions, doctors in different levels of medical units have different levels of understanding and attention to CRA. Therefore, it is particularly important to strengthen the standardized diagnosis and treatment of CRA. The effectiveness and safety of the presently accepted therapeutic approaches are defined. The new treatment methods are still in the research stage. The article reviews the status of diagnosis and treatment of CRA. \\n \\n \\nKey words: \\nNeoplasms; Anemia; Pathogenesis; Treatment\",\"PeriodicalId\":9505,\"journal\":{\"name\":\"肿瘤研究与临床\",\"volume\":\"31 1\",\"pages\":\"707-711\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"肿瘤研究与临床\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2019.10.015\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"肿瘤研究与临床","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1006-9801.2019.10.015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

肿瘤相关性贫血(CRA)是肿瘤患者在疾病发展和治疗过程中的并发症。研究表明，在非血液学恶性肿瘤中，贫血的发生率约为40%，而在肿瘤放化疗期间，贫血的发生率可达54%。CRA的发病机制尚未完全明确，国内外的研究也非常有限。CRA患者的生活质量和预后较差。在中国，由于经济水平和医疗条件发展的不平衡，不同层次医疗单位的医生对CRA的认识和重视程度不同。因此，加强CRA的规范化诊断和治疗显得尤为重要。定义了目前接受的治疗方法的有效性和安全性。新的治疗方法仍处于研究阶段。本文就CRA的诊断和治疗现状作一综述。关键词:肿瘤;贫血;发病机理;治疗

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Treatment progress of cancer-related anemia

Cancer-related anemia (CRA) is a complication of tumor patients in the development and treatment of diseases. Studies have shown that the incidence of anemia in non-hematologic malignancies is about 40%, and the incidence can reach 54% during tumor radiotherapy and chemotherapy. The pathogenesis of CRA has not been fully clarified, and studies at home and abroad are also very limited. The quality of life and prognosis of CRA patients are poor. In China, due to the imbalance of economic level and the development of medical conditions, doctors in different levels of medical units have different levels of understanding and attention to CRA. Therefore, it is particularly important to strengthen the standardized diagnosis and treatment of CRA. The effectiveness and safety of the presently accepted therapeutic approaches are defined. The new treatment methods are still in the research stage. The article reviews the status of diagnosis and treatment of CRA. Key words: Neoplasms; Anemia; Pathogenesis; Treatment

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

肿瘤研究与临床 Medicine-Oncology

CiteScore

0.10

自引率

0.00%

发文量

7737

期刊介绍： "Cancer Research and Clinic" is a series of magazines of the Chinese Medical Association under the supervision of the National Health Commission and sponsored by the Chinese Medical Association. It mainly reflects scientific research results and academic trends in the field of malignant tumors. The main columns include monographs, guidelines and consensus, standards and norms, treatises, short treatises, survey reports, reviews, clinical pathology (case) discussions, case reports, etc. The readers are middle- and senior-level medical staff engaged in basic research and clinical work on malignant tumors.